Teva Pharmaceutical Industries (TEVA) Preferred Dividend Payments (2016 - 2018)
Historic Preferred Dividend Payments for Teva Pharmaceutical Industries (TEVA) over the last 4 years, with Q4 2018 value amounting to $54.0 million.
- Teva Pharmaceutical Industries' Preferred Dividend Payments fell 1692.31% to $54.0 million in Q4 2018 from the same period last year, while for Dec 2018 it was $249.0 million, marking a year-over-year decrease of 423.08%. This contributed to the annual value of $249.0 million for FY2018, which is 423.08% down from last year.
- Teva Pharmaceutical Industries' Preferred Dividend Payments amounted to $54.0 million in Q4 2018, which was down 1692.31% from $65.0 million recorded in Q3 2018.
- In the past 5 years, Teva Pharmaceutical Industries' Preferred Dividend Payments registered a high of $66000.0 billion during Q2 2016, and its lowest value of $15.0 million during Q4 2015.
- For the 4-year period, Teva Pharmaceutical Industries' Preferred Dividend Payments averaged around $10000.1 billion, with its median value being $65.0 million (2016).
- As far as peak fluctuations go, Teva Pharmaceutical Industries' Preferred Dividend Payments skyrocketed by 33333.33% in 2016, and later tumbled by 9999.99% in 2017.
- Quarter analysis of 4 years shows Teva Pharmaceutical Industries' Preferred Dividend Payments stood at $15.0 million in 2015, then skyrocketed by 333.33% to $65.0 million in 2016, then changed by 0.0% to $65.0 million in 2017, then fell by 16.92% to $54.0 million in 2018.
- Its Preferred Dividend Payments stands at $54.0 million for Q4 2018, versus $65.0 million for Q3 2018 and $65.0 million for Q2 2018.